Robert W Postma Alaunos Therapeutics, Inc. (TCRT) insider trading activity

Robert W Postma is of Alaunos Therapeutics, Inc.. Currently has a direct ownership of 38,250 shares of TCRT, which is worth approximately $113,602. The most recent transaction as insider was on Nov 21, 2025, when has been sold 5,142 shares (Common Stock) at a price of $3.16 per share, resulting in proceeds of $16,248. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 38.3K

15.44% 3M change

96.92% 12M change

Total Value Held $113,602

Robert W Postma Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 21 2025	BUY Grant, award, or other acquisition	$16,248 $3.16 p/Share	5,142 Added 11.85%	38,250 Common Stock
Jul 03 2025	BUY Grant, award, or other acquisition	-	4,050 Added 10.89%	33,133 Common Stock
Apr 13 2025	BUY Grant, award, or other acquisition	$60,747 $2.92 p/Share	20,804 Added 41.7%	29,083 Common Stock
Apr 13 2025	BUY Grant, award, or other acquisition	$60,747 $2.92 p/Share	20,804 Added 41.7%	29,083 Common Stock
Jun 22 2022	BUY Grant, award, or other acquisition	-	40,000 Added 3.12%	1,241,870 Common Stock
Jun 22 2022	BUY Grant, award, or other acquisition	-	40,000 Added 3.12%	1,241,870 Common Stock
Sep 02 2021	BUY Open market or private purchase	$35,479 $1.73 p/Share	20,508 Added 1.68%	1,201,870 Common Stock

Mar 04 2021	BUY Grant, award, or other acquisition	-	2,500 Added 0.21%	1,181,362 Common Stock

RWP

Robert W Postma

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TCRT shares.

Notify only if

Value

Insider Trading

Get notified when an Alaunos Therapeutics, Inc. insider buys or sells TCRT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Alaunos Therapeutics, Inc.

Track Activities on TCRT

Account